Literature DB >> 6197665

Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.

K Yanagisawa, S Sato, N Amaya, T Miyatake.   

Abstract

A calcium-activated neutral protease (CANP) was extracted from human brain and partially purified. The activity was measured using alkali-denatured casein (Hammersten) as a substrate. The optimum pH was around 7.0. The activity required the presence of calcium ions, maximum activity was obtained with over 5 mM calcium ions. The Km for the casein concentration was about 1.62 mg/ml. The activity of CANP was inhibited by one of the thiol protease inhibitors, E-64 analogue (E-64-a). The rate of inhibition was about 50% at an E-64-a concentration of 10(-5)M. This CANP degraded selectively basic protein in myelin proteins and the degradation was inhibited by E-64-a or EGTA. The role of the brain CANP in the process of demyelination was suggested by this study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197665     DOI: 10.1007/bf00963998

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  The breakdown of myelin-bound proteins by intra- and extracellular proteases.

Authors:  N Marks; A Grynbaum; A Lajtha
Journal:  Neurochem Res       Date:  1976-02       Impact factor: 3.996

2.  Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization.

Authors:  S Ishiura; H Murofushi; K Suzuki; K Imahori
Journal:  J Biochem       Date:  1978-07       Impact factor: 3.387

3.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

4.  Partial characterization of a new myelin protein component.

Authors:  H C Agrawal; R M Burton; M A Fishman; R F Mitchell; A L Prensky
Journal:  J Neurochem       Date:  1972-09       Impact factor: 5.372

5.  Quaking mouse: isolation and characterization of myelin protein.

Authors:  S Greenfield; W T Norton; P Morell
Journal:  J Neurochem       Date:  1971-11       Impact factor: 5.372

6.  Amino acid sequence of the basic protein of the myelin membrane.

Authors:  E H Eylar
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

7.  Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.

Authors:  S Sato; R H Quarles; R O Brady
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

8.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

9.  The cytosol of human erythrocytes contains a highly Ca2+-sensitive thiol protease (calpain I) and its specific inhibitor protein (calpastatin).

Authors:  T Murakami; M Hatanaka; T Murachi
Journal:  J Biochem       Date:  1981-12       Impact factor: 3.387

10.  Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.

Authors:  S Sato; K Yanagisawa; T Miyatake
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

View more
  7 in total

1.  Isolation and characterization of cathepsin B from bovine brain.

Authors:  J D Bradley; J N Whitaker
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

2.  Degradation of myelin proteins by cathepsin B and inhibition by E-64 analogue.

Authors:  K Yanagisawa; S Sato; T Miyatake; E Kominami; N Katsunuma
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

3.  An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate.

Authors:  W Y Ong; L J Garey; K K Tan
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

4.  Purification and characterization of calpain from human polymorphonuclear leukocytes.

Authors:  J L Legendre; H P Jones
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

5.  Degradation of myelin basic protein in myelin by protease in cerebrospinal fluid and effects of protease inhibitors.

Authors:  T Inuzuka; S Sato; H Baba; T Miyatake
Journal:  Neurochem Res       Date:  1986-10       Impact factor: 3.996

6.  Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.

Authors:  S Sato; K Yanagisawa; T Miyatake
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

7.  Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.

Authors:  Arabinda Das; Naren L Banik; Sunil J Patel; Swapan K Ray
Journal:  Mol Cancer       Date:  2004-12-08       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.